About Abound Bio
Abound Bio is a company based in Pittsburgh (United States) founded in 2019 was acquired by Galapagos in June 2022. Abound Bio offers products and services including Antibody Therapeutics, Cell Therapy, and Small Molecules. Abound Bio operates in a competitive market with competitors including Novartis, Catalent, Surrozen, Biotage and Curia, among others.
- Headquarter Pittsburgh, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Galapagos Nv
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Abound Bio
Abound Bio offers a comprehensive portfolio of products and services, including Antibody Therapeutics, Cell Therapy, and Small Molecules.
Develops treatments for cancer using antibodies
Advances cell-based solutions for infectious diseases
Creates compounds for disease management
People of Abound Bio
Unlock access to complete
Unlock access to complete
Funding Insights of Abound Bio
Detailed funding history for Abound Bio
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Abound Bio
Abound Bio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include GLPG.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Small molecule drugs for immunology and oncology are developed.
|
Locked | Locked | Locked |
Investor details for Abound Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Abound Bio
Investment portfolio details for Abound Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Abound Bio
Detailed financials for Abound Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Abound Bio Comparisons
Peer comparison for Abound Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Abound Bio
Abound Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novartis, Catalent, Surrozen, Biotage and Curia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
|
| Locked | Locked | Locked |
CDMO offering drug and biologics development services
|
|
| Locked | Locked | Locked |
Selective Wnt agonists are developed for human tissue regeneration.
|
|
| Locked | Locked | Locked |
Organic synthesis, analytical, and peptide chemistry services for drug discovery and development
|
|
| Locked | Locked | Locked |
Drug research, development, testing, and consulting services are provided.
|
|
| Locked | Locked | Locked |
Provides contract research, development, and manufacturing services for biologic drugs.
|
Detailed competitors of Abound Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Abound Bio
Complete news archive for Abound Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abound Bio
Abound Bio was founded in 2019.
Abound Bio is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
Abound Bio was founded in 2019 and is based in Pittsburgh, United States. Operations are centered in the biotechnology sector, where discovery, development, and manufacturing services are delivered for cancer and infectious disease applications. Focus is maintained on supporting therapeutic advancements through these core functions, with activities conducted from the companys location in the United States. The domain aboundbio.com is utilized for online presence.
Abound Bio offers Antibody Therapeutics, Cell Therapy, and Small Molecules.
Abound Bio has 1 investor. Key investors include GLPG.